![Ras signaling is a key determinant of metastatic dissemination and poor survival of luminal breast cancer patients]()
Ras signaling is a key determinant of metastatic dissemination and poor survival of luminal breast cancer patientsWright, K. L.; Adams, J. R.; Liu, J. C.; Loch, A. J.; Wong, R. G.; Jo, C. E. B.; Beck, L. A.; Santhanam, D. R.; Weiss, L.; Mei, X.; Lane, T. F.; Koralov, S. B.; Done, S. J.; Woodgett, J. R.; Zacksenhaus, E.; Hu, P.; Egan, S. E. · Cancer Research · 2015